Safety profile of immune checkpoint inhibitors versus sorafenib as first-line treatment in advanced hepatocellular carcinoma: A meta-analysis of randomized controlled trials.

被引：0
|
作者：
Rizzo, Alessandro [1 ]
Frega, Giorgio [2 ]
Ricci, Angela Dalia [1 ]
Palloni, Andrea [1 ]
Tavolari, Simona [3 ]
Brandi, Giovanni [2 ]
机构：
[1] Univ Bologna, St Orsola Malpighi Hosp, Dept Expt Diagnost & Specialty Med DIMES, Bologna, Italy
[2] Policlin S Orsola Malpighi Hosp, Dept Expt Diagnost & Specialty Med, Bologna, Italy
[3] Univ Bologna, Bologna, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 03期
关键词：
D O I：
10.1200/JCO.2021.39.3_suppl.315
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
315
引用
收藏
页数：2
相关论文
共 50 条
  • [41] The efficacy and safety analysis of first-line immune checkpoint inhibitors in pulmonary sarcomatoid carcinoma
    Qian, Xiaoying
    Wang, Yong
    Liu, Fanrong
    Yuan, Yong
    Fang, Chen
    Zhang, Xinwei
    Yuan, Shangkun
    Chen, Renfang
    Yu, Biao
    Wang, Tong
    Yin, Yan
    Li, Yong
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [42] Surrogate endpoint in advanced hepatocellular carcinoma treated with molecular targeted therapy: Meta-analysis of randomized controlled trials.
    Lee, Kyung-Hun
    Lee, Dae-Won
    Jang, Myoung-Jin
    Kim, Tae-Yong
    Han, Sae-Won
    Oh, Do-Youn
    Im, Seock-Ah
    Kim, Tae-You
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [43] Transarterial chemoembolization in patients with unresectable hepatocellular carcinoma:: A meta-analysis of randomized controlled trials.
    Schepis, F
    Orlando, A
    Albanese, M
    Shahied, L
    Trevisani, F
    Andreone, P
    Craxi, A
    Cottone, M
    Cammà, C
    HEPATOLOGY, 2001, 34 (04) : 178A - 178A
  • [44] Immune checkpoint inhibitors in the peri-operative setting in renal cell carcinoma: A meta-analysis of the randomized clinical trials.
    Esteban Villarrubia, Jorge
    Carril-Ajuria, Lucia
    Carretero-Gonzalez, Alberto
    Romero Ferreiro, Carmen
    Alvarez, Pablo
    Ruiz-Vico, Maria
    Castellano, Daniel
    de Velasco, Guillermo
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [45] Patients with sarcomatoid renal cell carcinoma-re-defining the first-line of treatment: A meta-analysis of randomised clinical trials with immune checkpoint inhibitors
    Iacovelli, Roberto
    Ciccarese, Chiara
    Bria, Emilio
    Bracarda, Sergio
    Porta, Camillo
    Procopio, Giuseppe
    Tortora, Giampaolo
    EUROPEAN JOURNAL OF CANCER, 2020, 136 : 195 - 203
  • [46] Efficacy and safety of adding immune checkpoint inhibitors to first-line standard therapy for recurrent or advanced cervical cancer: a meta-analysis of phase 3 clinical trials
    Zhang, Xinmiao
    Shen, Jinhai
    Huang, Mengfan
    Li, Rongxia
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [47] Checkpoint inhibitors in combination with chemotherapy for first-line treatment of advanced non-small cell lung cancer: A systematic review and meta-analysis of randomized controlled trials (RCTs).
    Thein, Wai Lin
    Tun, Aung
    Thein, Kyaw Zin
    Guevara, Elizabeth
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [48] Efficacy and safety profile of sunitinib as a first line treatment for advanced/metastatic clear-cell renal cell carcinoma: Pooled analysis of randomized controlled trials.
    Haykal, Tarek
    Samji, Varun
    Zayed, Yazan
    Al-Dulaimi, Ragheed
    Gakhal, Inderdeep
    Bala, Areeg
    Sotzen, Jason
    Ghamrawi, Ranine
    Katato, Khalil
    Danish, Rizwan
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [49] Efficacy of treatment regimens for advanced hepatocellular carcinoma A network meta-analysis of randomized controlled trials
    Chen, Qi-Feng
    Wu, Pei-Hong
    Huang, Tao
    Shen, Lu-Jun
    Huang, Zi-Lin
    Li, Wang
    MEDICINE, 2019, 98 (40)
  • [50] Immune Checkpoints Inhibitors and Chemotherapy as First-Line Treatment for Metastatic Urothelial Carcinoma: A Network Meta-Analysis of Randomized Phase III Clinical Trials
    Chen, Hsiao-Ling
    Chan, Vinson Wai-Shun
    Tu, Yu-Kang
    Chan, Erica On-Ting
    Chang, Hsiu-Mei
    Juan, Yung-Shun
    Teoh, Jeremy Yuen-Chun
    Lee, Hsiang Ying
    CANCERS, 2021, 13 (06)
12345